258 related articles for article (PubMed ID: 35172688)
1. Mechanism of action of
Shi H; Hou Y; Su X; Qiao J; Wang Q; Guo X; Gao Z; Wang L
Ren Fail; 2022 Dec; 44(1):116-125. PubMed ID: 35172688
[TBL] [Abstract][Full Text] [Related]
2. A Network Pharmacology-Based Strategy for Unveiling the Mechanisms of Tripterygium Wilfordii Hook F against Diabetic Kidney Disease.
Wang Y; Liu T; Ma F; Lu X; Mao H; Zhou W; Yang L; Li P; Zhan Y
J Diabetes Res; 2020; 2020():2421631. PubMed ID: 33274236
[TBL] [Abstract][Full Text] [Related]
3. Exploring the Pharmacological Mechanisms of
Huang B; Huang C; Zhu L; Xie L; Wang Y; Zhu N
Biomed Res Int; 2021; 2021():5575621. PubMed ID: 34435046
[TBL] [Abstract][Full Text] [Related]
4. A network pharmacology study on the Tripteryguim wilfordii Hook for treatment of Crohn's disease.
Zhang J; Huang Q; Zhao R; Ma Z
BMC Complement Med Ther; 2020 Mar; 20(1):95. PubMed ID: 32293395
[TBL] [Abstract][Full Text] [Related]
5. Network pharmacology and molecular docking analysis on the mechanism of Tripterygium wilfordii Hook in the treatment of Sjögren syndrome.
Wang Z; Xu Y; Liang S
Medicine (Baltimore); 2024 Apr; 103(14):e37532. PubMed ID: 38579044
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanism of reproductive toxicity induced by Tripterygium Wilfordii based on network pharmacology.
Ding Q; Wu Y; Liu W
Medicine (Baltimore); 2021 Jul; 100(27):e26197. PubMed ID: 34232166
[TBL] [Abstract][Full Text] [Related]
7. Exploring the pharmacological mechanism of Tripterygium wilfordii hook for treatment of Behcet's disease using network pharmacology and molecular docking.
Ye L; Li C; Zhao X; Ou W; Wang L; Wan M
Medicine (Baltimore); 2023 Oct; 102(42):e34512. PubMed ID: 37861497
[TBL] [Abstract][Full Text] [Related]
8. Review of molecular biological research on the treatment of membranous nephropathy with Tripterygium glycosides based on TCM theory.
Xu P; Fu G; Zhao H; Wang M; Ye H; Shi K; Zang P; Su X
Medicine (Baltimore); 2023 Nov; 102(45):e34686. PubMed ID: 37960769
[TBL] [Abstract][Full Text] [Related]
9. Integrating network pharmacology and experimental verification to explore the mechanism of Tripterygium wilfordii in ankylosing spondylitis.
Chen Y; Liu Z; Yu Q; Qu X; Liu H
Medicine (Baltimore); 2023 Dec; 102(50):e36580. PubMed ID: 38115356
[TBL] [Abstract][Full Text] [Related]
10. Research on the Mechanism of Guizhi to Treat Nephrotic Syndrome Based on Network Pharmacology and Molecular Docking Technology.
He D; Li Q; Du G; Sun J; Meng G; Chen S
Biomed Res Int; 2021; 2021():8141075. PubMed ID: 34873575
[TBL] [Abstract][Full Text] [Related]
11. Potential shared therapeutic and hepatotoxic mechanisms of Tripterygium wilfordii polyglycosides treating three kinds of autoimmune skin diseases by regulating IL-17 signaling pathway and Th17 cell differentiation.
Chen Y; Wang YF; Song SS; Zhu J; Wu LL; Li XY
J Ethnopharmacol; 2022 Oct; 296():115496. PubMed ID: 35750104
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of
Lu L; Peng J; Wan P; Peng H; Lu J; Xiong G
Front Pharmacol; 2022; 13():940773. PubMed ID: 36386135
[No Abstract] [Full Text] [Related]
13. Tripterygium wilfordii multiglycosides combined with prednisone in the treatment of idiopathic membranous nephropathy: A protocol for a systematic review and meta-analysis.
Jin Y; Zhang J; Wang Y; Xiao X; Zhang Q
Medicine (Baltimore); 2020 Jan; 99(5):e18970. PubMed ID: 32000425
[TBL] [Abstract][Full Text] [Related]
14. Exploration of the Mechanism of Tripterygium Wilfordii in the Treatment of Myocardial Fibrosis Based on Network Pharmacology and Molecular Docking.
Ming Y; Jiachen L; Tao G; Zhihui W
Curr Comput Aided Drug Des; 2023; 19(1):68-79. PubMed ID: 36306461
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacodynamic effect and virulent effect of Tripterygium wilfordii based on network pharmacology].
Dong YZ; Zhang B; Lin ZJ; Zhang XM
Zhongguo Zhong Yao Za Zhi; 2019 Aug; 44(16):3460-3467. PubMed ID: 31602910
[TBL] [Abstract][Full Text] [Related]
16. Network pharmacology and molecular docking predictions of the active compounds and mechanism of action of Huangkui capsule for the treatment of idiopathic membranous nephropathy.
Cai M; Xiang Y; Li Z; Xie J; Wen F
Medicine (Baltimore); 2023 Sep; 102(37):e35214. PubMed ID: 37713831
[TBL] [Abstract][Full Text] [Related]
17. Network Pharmacology-Based and Molecular Docking-Based Analysis of Suanzaoren Decoction for the Treatment of Parkinson's Disease with Sleep Disorder.
Liu YY; Yu LH; Zhang J; Xie DJ; Zhang XX; Yu JM
Biomed Res Int; 2021; 2021():1752570. PubMed ID: 34660782
[TBL] [Abstract][Full Text] [Related]
18. Exploring the mechanisms underlying the therapeutic effect of Salvia miltiorrhiza in diabetic nephropathy using network pharmacology and molecular docking.
Zhang L; Han L; Wang X; Wei Y; Zheng J; Zhao L; Tong X
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 33634308
[TBL] [Abstract][Full Text] [Related]
19. Exploring the pharmacological mechanisms of
Lu M; Ou J; Deng X; Chen Y; Gao Q
Heliyon; 2023 Jun; 9(6):e17550. PubMed ID: 37416640
[TBL] [Abstract][Full Text] [Related]
20. Network Pharmacology-based Strategy to Investigate Pharmacological Mechanisms of Qingbutongluo Pill for Treatment of Brucellosis.
Wang J; He JW; Liu JS; Li JE; Cui QY; Wang YR; Zhou WG
Comb Chem High Throughput Screen; 2023; 26(4):706-718. PubMed ID: 35692141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
